Avalo Therapeutics discontinues multiple myeloma program; stock plunges 23%
07 January 2022 - 2:24AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Apr 2023 to Apr 2024